T2 Biosystems, Inc.
(NASDAQ : TTOO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.11%194.531.3%$535.65m
GILDGilead Sciences, Inc.
-0.33%65.950.9%$358.83m
ALXNAlexion Pharmaceuticals, Inc.
-4.10%103.412.0%$312.20m
ILMNIllumina, Inc.
1.10%301.553.5%$306.56m
BIIBBiogen Inc.
-1.46%235.221.3%$295.33m
CELGCelgene Corporation
0.07%98.671.3%$288.57m
AAgilent Technologies, Inc.
0.54%76.811.6%$174.28m
SRPTSarepta Therapeutics, Inc.
-2.63%82.6514.6%$174.16m
VRTXVertex Pharmaceuticals Incorporated
-0.58%174.981.9%$173.53m
REGNRegeneron Pharmaceuticals, Inc.
-1.75%283.082.6%$169.58m
EXASExact Sciences Corporation
-1.59%105.1724.1%$133.04m
ACADACADIA Pharmaceuticals Inc.
-4.20%40.8113.9%$110.14m
INCYIncyte Corporation
-1.04%78.282.5%$84.83m
BMRNBioMarin Pharmaceutical Inc.
0.04%75.034.3%$71.26m
ALDRAlder Biopharmaceuticals, Inc.
0.47%18.7910.2%$64.25m

Company Profile

T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.